Unveiling Innovation: Liquidia’s Poster Presentation at the 2023 American Conference
Liquidia Corporation to Present Data on YUTREPIA™ at ATS International Conference MORRISVILLE, N.C., May 19, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the Company will present data related to the investigational use of YUTREPIA™ (treprostinil) inhalation powder at the 2023 American Thoracic Society (ATS) International Conference, taking place…